Medical News

RSS
MicroBiome Therapeutics announces completion of $1.3M bridge financing

MicroBiome Therapeutics announces completion of $1.3M bridge financing

TELUS Health to offer Medworxx Patient Flow Platform to customers

TELUS Health to offer Medworxx Patient Flow Platform to customers

Glioblastoma multiforme patients treated with experimental vaccine show improved survival

Glioblastoma multiforme patients treated with experimental vaccine show improved survival

First Edition: December 16, 2013

First Edition: December 16, 2013

Two UTHealth professors elected fellows of American Association for the Advancement of Science

Two UTHealth professors elected fellows of American Association for the Advancement of Science

Better to fat finger a text than to lose a finger due to the cold

Better to fat finger a text than to lose a finger due to the cold

Experimental drug that targets macrophages decreases cancer's growth

Experimental drug that targets macrophages decreases cancer's growth

Queen's University professor wins Gold Award for Innovation for research on male infertility

Queen's University professor wins Gold Award for Innovation for research on male infertility

OncoSec Medical reports positive interim data from OMS-I100 Phase 2 trial for metastatic melanoma

OncoSec Medical reports positive interim data from OMS-I100 Phase 2 trial for metastatic melanoma

New classification system to manage emergency surgery described in special issue of  BJS

New classification system to manage emergency surgery described in special issue of BJS

Stem cell technology: an interview with Professor Igor Slukvin, University of Wisconsin-Madison and scientific founder of CDI and Cynata

Stem cell technology: an interview with Professor Igor Slukvin, University of Wisconsin-Madison and scientific founder of CDI and Cynata

NYSE publicly traded industry selects EPGL's advanced technologies for development

NYSE publicly traded industry selects EPGL's advanced technologies for development

Data show that HCV genotype-1 infected patients may benefit from faldaprevir

Data show that HCV genotype-1 infected patients may benefit from faldaprevir

State highlights: Fewer visits to Texas women's clinics after planned parenthood exclusion; Minn. health spending growth slows

State highlights: Fewer visits to Texas women's clinics after planned parenthood exclusion; Minn. health spending growth slows

Cellular Biomedicine Group completes TC-DC Phase I clinical trial for hepatocellular carcinoma

Cellular Biomedicine Group completes TC-DC Phase I clinical trial for hepatocellular carcinoma

Viewpoints: States need to expand Medicaid to benefit all; lies about immigrants and doctors; antibiotics and animals

Viewpoints: States need to expand Medicaid to benefit all; lies about immigrants and doctors; antibiotics and animals

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

JHI releases epic3 guidelines on infection prevention for healthcare professionals

JHI releases epic3 guidelines on infection prevention for healthcare professionals

Drug abuse appears to foster brain changes that resemble schizophrenia

Drug abuse appears to foster brain changes that resemble schizophrenia

Research roundup: Long-term care use varies dramatically by state; health spending slowdown explained

Research roundup: Long-term care use varies dramatically by state; health spending slowdown explained

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.